CIAM
DNA icon

Caitong International Asset Management’s Ginkgo Bioworks DNA Stock Holding History

Caitong International Asset Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,182
Closed -$13.3K – 2076
2025
Q2 		$13.3K Buy
1,182
+60
+5% +$465 0.01% 627
2025
Q1 		$6.39K Sell
1,122
-61
-5% -$621 ﹤0.01% 964
2024
Q4 		$11.6K Buy
+1,183
New +$10.1K 0.01% 926

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Caitong International Asset Management's DNA Position: Q3 2025 in Review

Caitong International Asset Management sold out of Ginkgo Bioworks (DNA) in Q3 2025, closing a stake of 1,182 shares — an estimated $13.3K sold.

Caitong International Asset Management first reported a position in DNA in Q4 2024 and held it in 3 quarters. The position peaked at $13.3K in Q2 2025. 173 funds tracked by Wall St. Rank hold DNA as of Q3 2025.

  • Caitong International Asset Management reported no remaining Ginkgo Bioworks position as of Q3 2025 after selling out during the quarter.
  • Caitong International Asset Management sold 1,182 Ginkgo Bioworks shares in Q3 2025, an estimated $13.3K.
  • Caitong International Asset Management first reported a position in Ginkgo Bioworks in Q4 2024 and held it in 3 quarters.
  • Caitong International Asset Management's Ginkgo Bioworks position peaked at $13.3K in Q2 2025.
  • 173 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2025.

Based on Caitong International Asset Management's 13F filing for Q3 2025, filed 19 Nov 2025.